Board Objectives Tracker 2026/27
Click a status pill to cycle TBC → Green → Amber → Red → N/A. Click a note to edit it. Changes save automatically.
TBC 42
Green 2
Amber 2
Red 0
N/A 0
1Digital Services
Deliver £12.3m revenue from service-based delivery.
GSK Contractors
Increase GSK contractors to 28 and explore new growth opportunities. Target: 28 GSK + 4 from others (£4.7m). Stretch: +10% to £5.2m.
AZ Autonomous
Deliver £2.0m AZ autonomous value; introduce autonomous/equivalent to 1 new client. Stretch: +25% to £2.5m.
AZ OT
Deliver £3.4m AZ OT projects. Stretch: £225k growth.
Overall Margin
Target overall margin of 23%.
IKA Growth
Grow IKA business to £250k from £120k base (£120k revenue pro rata this year). Stretch: £130k growth.
Data & AI (DAAI)
Deliver £447k of data & AI services @36% margin. Stretch: +50% to £650k.
Sustainability
Deliver £195k of sustainability services @73% margin. Stretch: +50% to £290k.
Manufacturing & Supply Chain
Deliver £775k of manufacturing & supply chain services @21% margin. Maximise Westgate and PWC opportunities. Stretch: +10% to £850k.
Training
Deliver £201k of training services @86% margin.
2Products
Deliver £1.02m revenue from product sales and support @ 74% margin.
CAST / SieCAST Sales
Deliver £635k from CAST and SieCAST sales. Maximise global launch with Siemens. 2 new pharma clients implemented. Stretch: +50% to £950k.
DASH Sales
Deliver £172k of DASH and support sales. Launch in October '26. Channel partnership model strategy understood. Stretch: +50% to £250k.
PHASE Sales
Deliver £210k PHASE sales. 3 new pharma clients implemented. Channel partnership model strategy understood. Stretch: +50% to £315k.
Bespoke Applications incl. Training
Deliver £200k of bespoke applications and training products. Stretch: +50% to £450k.
Reseller Opportunities
Implement reseller opportunities — deliver stretch value from Opswat and Veeva Light programme. Budget upside opportunity of £150k.
3Capability, Capacity & Process
Ensure capability, capacity and processes are in place to deliver the DTG business plan for 2026/27 and beyond.
Financial and Legal
R&D Tax Credit
Maximise the R&D tax credit opportunity — submission August.
Share Scheme
Implement new share scheme — September.
US Cash Flow
Secure cash flow for contractor growth in US — August.
IKA Purchase
Complete purchase of IKA (September).
Grant Support
Land £175k of grant support.
Compliance
Leadership & Governance
Develop the leadership, governance and staff development processes (e.g. pension, training & dev).
Skills & Capability
Develop the skills and capabilities within DTG to deliver the strategic ambition, leveraging strategic partners where necessary.
Compliance Standards
Maintain ISO 9001 & 27001, Cyber Essentials Plus and Ecovadis accreditation; implement eQMS (October) and ISO 14000.
Facilities
New Office
Ensure DTG has the infrastructure, equipment and facilities to deliver the growth plan. New office operational by September.
Marketing & BD Processes
Marketing Strategy
Develop marketing strategy for data & AI, sustainability, bespoke applications and manufacturing & supply chain transformation by no later than October.
DASH Launch
Launch DASH in October.
Plvs Ultra Marketing
Expand marketing strategy for Plvs Ultra into Healthtech and other markets.
BD & Sales Process
Enhance BD and sales processes to improve prospecting, order winning to PO.
HubSpot
Implement HubSpot for sales dashboarding.
Major Client Win
Secure additional major client — digital services/autonomous.
4Extending Our Reach
Extend DTG's reach to access new clients, products, technology and markets, enabling at least 25% growth in revenue in FY27/28.
Strategic Partnerships
Partnership Model
Implement an improved technology and consultancy partnership business model for DTG, providing differentiation and improved financial outcomes.
Associates Programme
Implement a DTG associates programme to maximise the value from our stakeholder group.
Regional Growth — US, Singapore, Ireland
US Growth
Deliver foundations for £2m+ opportunity in 27/28 @ Virginia and £150k from at least 1 new client.
Singapore Growth
Deliver foundations for £0.5m opportunity in 26/27. Implement 1 new client by end '26. Sign membership of PIPs and ARTC programmes.
Ireland Growth
Establish capability to exploit DTG products and services within Ireland.
Products and Technology Growth
Carbon Footprint Offering
Enhance our offering in carbon footprint to create an end-to-end digital thread via PU development into PHASE Plus.
New Technology Strategy
Develop strategic plan for new technology offerings, e.g. RTLS and/or digital twin capability and partnering.
Bespoke Product Growth
Opportunistic growth on bespoke products (Maturity, EHS, UNS etc).
Product Sales
Channel Partnerships
Implement and/or optimise channel partnership models to maximise product sales.
CAST/SieCAST Partnership
Optimise Siemens opportunity and create partnership with 1 other organisation (e.g. Emerson) to create a pathway to £2m sales.
PHASE Partnerships
Evaluate Allocnow, ERM, Plvs Ultra and Siemens Advanta to create a pathway to £2m sales.
DASH Partnership
Evaluate Veeva partnering opportunity.
5DTG Investment Co
Provide leadership and direction to invested companies to ensure a fast and optimal ROI.
Plvs Ultra
Provide strategic marketing and sales support, targeting £300k+ income in 26/27. Resolve cash flow concerns through sales growth and/or investor introduction. Develop partnership opportunities for scale-up and/or purchase — Veeva, ATOS, Emerson, Google and AWS.
BioSimax
Lead Round A investment programme with Bowmore and 22.5, raising £35m to take the company through its clinical milestone. Actively shape the future leadership team structure and maximise opportunity for DTG. Evaluate Abu Dhabi life science spin-off via Bowmore and 22.5.
Pivot-DC
Provide Shareholder and CFO leadership.
Winters Renewables and Sustainability (WRS)
Complete equity investment in WRS and support year 1 growth through partnering with the sustainability business offering.
IKA
Complete purchase of IKA and deliver growth ambition for 26/27. Develop 3-year business model for growth.